Company Filing History:
Years Active: 2008-2023
Title: Kwok Pui Fung: Innovator in Antimicrobial Treatments and SARS Research
Introduction
Kwok Pui Fung is a notable inventor based in Hong Kong, CN. He has made significant contributions to the fields of immunochemistry and pharmacology. With a total of 2 patents, his work focuses on innovative treatments for bacterial infections and severe acute respiratory syndrome (SARS).
Latest Patents
Kwok Pui Fung's latest patents include a groundbreaking discovery in the combination treatment of bacterial infections. This invention highlights the combined use of kuraridin and epicatechin gallate (ECG) to enhance antimicrobial activity, particularly against Staphylococcal species. Additionally, he has developed methods and compositions for diagnosing and treating SARS CoV infection. This patent discloses nucleic acids and peptides of the spike glycoprotein of SARS CoV, which are essential for creating prognostic and therapeutic compositions for individuals at risk of contracting the virus.
Career Highlights
Kwok Pui Fung is affiliated with The Chinese University of Hong Kong, where he continues to advance research in his field. His work has garnered attention for its potential impact on public health, particularly in combating bacterial infections and viral diseases.
Collaborations
He has collaborated with esteemed colleagues, including Kwok Wing Tsui and Siu Chung Stephen Chim, to further enhance the scope and effectiveness of his research.
Conclusion
Kwok Pui Fung's innovative contributions to antimicrobial treatments and SARS research underscore his importance in the scientific community. His patents reflect a commitment to improving health outcomes through advanced medical research.